All Stories

  1. Investigación en enfermería: Una visión actual
  2. Determinants and impact of alexithymia on quality of life in Parkinson's disease
  3. Satisfaction With Telemedicine Consultation as Follow-Up Visit in Patients with Parkinsonism and Essential Tremor in during the Covid-19 Pandemic
  4. Assessment of therapeutic strategies for management of impulse control disorder in Parkinson’s disease
  5. Frontal functional connectivity and disease duration interactively predict cognitive decline in Parkinson's disease
  6. Incidencia y distribución geográfica de la enfermedad de Parkinson en México
  7. Malnutrition and Associated Motor and Non-motor Factors in People with Parkinson's Disease
  8. Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
  9. Neuropsychiatric profile of patients with craniocervical dystonia: A case-control study
  10. Independence of Coping Styles With the Patient–Doctor Relationship and Shared Decision-Making in People With Parkinson’s Disease
  11. Teaching neurology to “Millennials:” Basic concepts and recommendations
  12. Association Between Somatization and Nonmotor Symptoms Severity in People With Parkinson Disease
  13. Factores asociados con deterioro cognitivo en una cohorte mexicana multicéntrica de Parkinson: estudio transversal comparativo
  14. Falls in persons with Parkinson's disease: Do non-motor symptoms matter as much as motor symptoms?
  15. Incidence rates of Parkinson’s disease in Mexico: Analysis of 2014-2017 statistics
  16. Air Pollution, Multiple Sclerosis and its Relevance to Mexico City
  17. Terapias de infusión en la enfermedad de Parkinson avanzada
  18. Brief historical review of Parkinson’s disease at 200 years of its description
  19. Diagnostic Utility of [11C]DTBZ Positron Emission Tomography In Clinically Uncertain Parkinsonism: Experience of a Single Tertiary Center
  20. Breve recorrido histórico de la enfermedad de Parkinson a 200 años de su descripción
  21. Motor and non-motor wearing-off and its impact in the quality of life of patients with Parkinson's disease
  22. Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients
  23. Etiología, fenomenología, clasificación y tratamiento de la distonía
  24. Indirect Costs of Parkinson Disease Health Care in the National Institute of Neurology and Neurosurgery in the Mexico City
  25. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations
  26. Brain oscillations reveal impaired novelty detection from early stages of Parkinson's disease
  27. Two-hundred Years Later: Is Parkinson�s Disease a Single Defined Entity?
  28. Premotor symptoms and the risk of Parkinson’s disease: A case-control study in Mexican population
  29. Thirty first annual symposium on etiology, pathogenesis, and treatment of Parkinson disease and other movement disorders: Presented by the Parkinson study group, huntington study group, dystonia study group, tourette syndrome study group, cooperative a...
  30. Association of polymorphisms and reduced expression levels of the NR4A2 gene with Parkinson's disease in a Mexican population
  31. Spotlight on olfactory dysfunction in Parkinson's disease
  32. Who Can Diagnose Parkinson's Disease First? Role of Pre-motor Symptoms
  33. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration
  34. Clinical Determinants of Parkinson's Disease-associated Pain Using the King's Parkinson's Disease Pain Scale
  35. Self-Perceived Pre-Motor Symptoms Load in Patients with Parkinson’s Disease: A Retrospective Study
  36. Frequency and clinical correlates of postural and striatal deformities in Parkinson’s disease
  37. A systematic review and mixed treatment comparison of monotherapy in early Parkinson’s disease: implications for Latin America
  38. Visuospatial, visuoconstructive and visuoperceptive functioning in patients with Parkinson's disease
  39. Theory of the mind in subjects with Parkinson's disease: A case-control study
  40. Lack of Association between Impulse Control Disorders and REM Sleep Behavior Disorder in Patients with Parkinson’s Disease
  41. Convergent validation of EQ-5D-5L in patients with Parkinson's disease
  42. Delusional Parasitosis as a Treatment Complication of Parkinson Disease
  43. No Difference on Adherence Between Immediate-Release Versus Extended-Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease
  44. Impact of Neuropsychiatric Symptoms on the Quality of Life of Subjects with Parkinson’s Disease
  45. Electroconvulsive therapy in Parkinson´s disease
  46. Factores asociados a la calidad de vida de sujetos con enfermedad de Parkinson y a la carga en el cuidador
  47. Prevalence and correlates of sleep disorders in Parkinson’s disease: a polysomnographic study
  48. Change in Motor and Nonmotor Symptoms Severity in a “Real-Life” Cohort of Subjects with Parkinson’s Disease
  49. Relación entre el polimorfismo DRD2/ANKK1 y el desarrollo de complicaciones motoras en enfermedad de Parkinson
  50. A Polysomnographic Study of Parkinson’s Disease Sleep Architecture
  51. Impulse control and related disorders in Mexican Parkinson's disease patients
  52. Comparing the accuracy of different smell identification tests in Parkinson’s disease: Relevance of cultural aspects
  53. Simultaneous Presentation of Ocular Flutter in Two Sisters
  54. Clinical, imaging, and molecular findings in a sample of Mexican families with pantothenate kinase-associated neurodegeneration
  55. Comparison of the Montreal Cognitive Assessment and Mini Mental State Examination Performance in Patients with Parkinson’s disease with w Low Educational Background
  56. ¿Enfermedad de Parkinson o síndrome de enfermedad de Parkinson?
  57. Vas Eq-5d Utility Index In Parkinson’s Disease
  58. Direct Medical Costs Related To Parkinson’s Disease
  59. A reappraisal of the ten steps test for identifying atypical parkinsonism
  60. Low specificity and sensitivity of smell identification testing for the diagnosis of Parkinson?s disease
  61. Independent Validation of the SEND-PD and Correlation with the MDS-UPDRS Part IA
  62. Cervical Dystonia
  63. Apathy and associated factors in Mexican patients with Parkinson’s disease
  64. Blood Pressure After Recent Stroke: Baseline Findings From the Secondary Prevention of Small Subcortical Strokes Trial
  65. Respuesta ortostática de la tensión arterial de pacientes con enfermedad de Parkinson inicial
  66. Clinical Determinants of Health-related Quality of Life in Mexican Patients with Parkinson’s Disease
  67. Prevalence and determinants of depression in Mexican patients with Parkinson's disease
  68. Overweight is more prevalent in patients with Parkinson's disease
  69. Opsoclonus Myoclonus Syndrome associated with GQ1b Antibodies
  70. Caffeine drinking, cigarette smoking, and dopaminergic replacement therapy dose in Parkinson’s disease
  71. A prospective series of patients with hyperglycaemia-associated movement disorders
  72. Detección y manejo de síntomas no motores en la enfermedad de Parkinson: impacto en su prevalencia
  73. Relación entre el tipo y lado de inicio de la sintomatología motora con la frecuencia de síntomas no motores en la enfermedad de Parkinson
  74. Sympathetic Cooling in an Optically Trapped Mixture of Alkali and Spin-Singlet Atoms
  75. Relationship between the type and side of motor symptoms with the prevalence of non-motor symptoms in Parkinson's disease
  76. Prevalence of non-motor dysfunction among Parkinson's disease patients from a tertiary referral center in Mexico City
  77. Use of smell test identification in Parkinson's disease in Mexico: A matched case-control study
  78. SEQUENTIAL STAR FORMATION IN A COMETARY GLOBULE (BRC37) OF IC1396
  79. Uso clínico de autoanticuerpos en neurología
  80. Quality of life in patients with Parkinson's disease